why is Biogen stock down in the dumps? I don’t get it. No matter how many positives Wall Street keeps punishing us
Quite simple. The entire growth of the organization lies in a medication that has failed 20 other times in Alz. Biogen is convinced it will get approved, and frankly the fda could care less if it meets its primary endpoint. As long as the drug can show “anything” in the positive it will get approval. Wall Street realizes everything hinges on 1 product. MS is dying a slow death, Tecfidera will erode like a beach under Hurricane Watch. There’s your answer. Good day.
You referencing the age discrimination case in RTP manufacturing? A quick Google search will give you that info.
